Sangamo Therapeutics (SGMOQ) Tax Provisions (2015 - 2025)
Sangamo Therapeutics (SGMOQ) posted quarterly Tax Provisions of -$553000.0 for Q4 2025, down 29.51% year-over-year from -$784488.4 in Q4 2024, and down 243.48% quarter-over-quarter from -$161000.0 in Q3 2025.
Sangamo Therapeutics (SGMOQ) Tax Provisions (2015 - 2025) Analysis & Trends
Sangamo Therapeutics' Tax Provisions history runs 8 years deep, the most recent figure standing at -$553000.0 for Q4 2025.
- In Q4 2025, Tax Provisions fell 29.51% year-over-year to -$553000.0; the TTM figure through Dec 2025 stood at -$568000.0 (down 240.12% YoY), while the FY2025 annual figure was -$568000.0, down 240.12% from the prior year.
- Tax Provisions for Q4 2025 stood at -$553000.0, down from -$161000.0 in the prior quarter.
- The five-year high for Tax Provisions was $1.3 million in Q3 2023, with the low at -$6.3 million in Q2 2023.
- The 5-year median for Tax Provisions is $66000.0 (2022), against an average of -$254450.0.
- Peak annual rise in Tax Provisions reached 4133.33% in 2023, while the deepest fall reached 7739.02% in 2023.
- Sangamo Therapeutics' Tax Provisions stood at -$67000.0 in 2021, then jumped by 441.79% to $229000.0 in 2022, then tumbled by 218.78% to -$272000.0 in 2023, then tumbled by 56.99% to -$427000.0 in 2024, then declined by 29.51% to -$553000.0 in 2025.
- Business Quant data shows SGMOQ's Tax Provisions at -$553000.0 in Q4 2025, -$161000.0 in Q3 2025, and $27000.0 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -553,000.00 |
| Sep 30, 2025 | -161,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Dec 31, 2024 | -427,000.00 |
| Sep 30, 2024 | 88,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Dec 31, 2023 | -272,000.00 |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | -6.26 Mn |
| Mar 31, 2023 | 194,000.00 |
| Dec 31, 2022 | 229,000.00 |
| Sep 30, 2022 | 30,000.00 |
| Jun 30, 2022 | 82,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Dec 31, 2021 | -67,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | 262,000.00 |